Join to View Full Profile
3800 Park Nicollet BlvdMinneapolis, MN 55416
Phone+1 952-993-3900
Fax+1 952-993-1761
Dr. Criego is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Amy Criego is a Pediatric Endocrinologist located in Minneapolis, MN, with a specialization in the management of diabetes in children. Dr. Criego completed pediatric residency at DeVos Children's Hospital and Michigan State University, followed by a fellowship in Pediatric Endocrinology at the University of Minnesota, where Dr. Criego also earned a Master's in Clinical Research. Since 2005, Dr. Criego has been practicing as a Pediatric Endocrinologist at Park Nicollet Clinic, has been Department Chair for Pediatric Endocrinology since 2013 and has served as Medical Director at the International Diabetes Center since 2016. Dr. Criego has authored numerous publications focusing on diabetes management and technology, including studies on automated insulin delivery systems, and has been involved in multiple clinical trials related to new diabetes treatment technologies.
Education & Training
University of MinnesotaMS, Clinical Research , 2002 - 2005
University of MinnesotaFellowship, Pediatric Endocrinology, 2002 - 2005
Corewell Health Helen DeVos Children's Hospital/Michigan State UniversityResidency, Pediatrics, 1999 - 2002
University of North Dakota School of Medicine and Health SciencesClass of 1999
Certifications & Licensure
MN State Medical License 2003 - 2026
WI State Medical License 2014 - 2015
MI State Medical License 1999 - 2002
American Board of Pediatrics Pediatric Endocrinology
Clinical Trials
- Threshold Suspend in Pediatrics at Home Start of enrollment: 2014 Jun 01
- Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control at Home Start of enrollment: 2017 May 25
- Day and Night Closed-loop in Young People With Type 1 Diabetes Start of enrollment: 2017 May 12
Publications & Presentations
PubMed
- 1 citationsAGP Reports for Glucose and Insulin Devices Qualitative Study: What Patients and Clinicians Want.Deborah M Mullen, Richard M Bergenstal, Mary Johnson, Eda Cengiz, Amy Criego
The Science of Diabetes Self-Management and Care. 2025-06-01 - Automated basal insulin delivery versus multiple daily injections in type 1 diabetes: results from a randomized parallel controlled trial.Johan H Jendle, Satish K Garg, Charles Thivolet, Ruth S Weinstock, Irl B Hirsch
Frontiers in Endocrinology. 2025-01-01 - 7 citationsPsychosocial outcomes with the Omnipod® 5 Automated Insulin Delivery System in caregivers of very young children with type 1 diabetes.Sarah A MacLeish, Korey K Hood, William H Polonsky, Jamie R Wood, Bruce W Bode
Diabetes, Obesity & Metabolism. 2024-12-01
Press Mentions
- Flash Glucose Monitoring Reduces Rate of Acute Diabetes Events 2 Years After InitiationAugust 19th, 2022
- Omnipod® 5 Automated Insulin Delivery System Significantly Improves Glycemic Outcomes at 12 Months of Use in Children 2 to 5.9 Years of AgeJune 3rd, 2022
- CGM as Medicine: Technology Benefits Extend to Type 2 DiabetesNovember 22nd, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
